CN Patent

CN114144185A — 用于治疗胆汁淤积性肝病的包含fxr激动剂和贝特类的药物组合物

Assigned to Intercept Pharmaceuticals Inc · Expires 2022-03-04 · 4y expired

What this patent protects

本发明涉及包含FXR激动剂和贝特类的组合的药物组合物。还公开了该组合用于治疗、改善或预防FXR介导的疾病或状况诸如原发性胆汁性胆管炎(PBC)的用途。

USPTO Abstract

本发明涉及包含FXR激动剂和贝特类的组合的药物组合物。还公开了该组合用于治疗、改善或预防FXR介导的疾病或状况诸如原发性胆汁性胆管炎(PBC)的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN114144185A
Jurisdiction
CN
Classification
—
Expires
2022-03-04
Drug substance claim
No
Drug product claim
No
Assignee
Intercept Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.